Lidocaine, Solution for Injection, 100 Mg/Ml, 2 Ml Tender - 145153521

Procurement Summary

Country: Ukraine

Summary: Lidocaine, Solution for Injection, 100 Mg/Ml, 2 Ml Each; Metamizole Sodium, Solution for Injection, 500 Mg/Ml, 2 Ml; Lidocaine, Solution for Injection, 20 Mg/Ml, 2 Ml Each; Magnesium Sulfate, Solution for Injection, 250 Mg...

Deadline: 14 Jul 2026

Posting Date: 15 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 145153521

Document Ref. No.: UA-2026-07-09-009059-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 60747.66

CPV Classification

33600000 - Pharmaceutical products
33660000 - Medicinal products for the nervous system and sensory organs
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33640000 - Medicinal products for the genitourinary system and hormones

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Lidocaine, solution for injection, 100 mg/ml, 2 ml each; Metamizole sodium, solution for injection, 500 mg/ml, 2 ml; Lidocaine, solution for injection, 20 mg/ml, 2 ml each; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Dexamethasone, solution for injection 4mg/ml; Theophylline solution for injection 20 mg/ml in 5 ml; Chloropyramine, solution for injection, 20 mg/ml, 1 ml each; Epinephrine 1.82 mg/ml, solution for injection, ampoule; Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule; Sodium chloride, solution for injection, 9 mg/ml, 5 ml each; Sodium chloride, solution for infusions, 9 mg/ml 200 ml; Sodium chloride, solution for infusions, 9 mg/ml 400 ml; Sulfacil eye drops 300 mg/ml, 10 ml, bottle; Miramistin eye/ear/nasal drops 0.1 mg/ml 5 ml; Chloramphenicol eye drops 0.25%; Ammonia, solution for external use, 10%, 40 ml each; Lugol's solution 25 g each; Povidone-iodine, solution for external use, 10%, 120 ml each; Chloramphenicol/methyluracil ointment 7.5 mg/40 mg per 40 g; Glucose solution for injections 40% in 10 ml; furosemide, solution for injections, 10 mg/ml, 2 ml each; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; Salbutamol, inhalation under pressure, 100 μg/dose, 200 doses; Prednisone, solution for injection, 30 mg/ml, 1 ml each; Captopril, tablets, 25 mg each; Barbiturates in combinations (a-bromosovaleric acid ethyl ether 18 mg, phenobarbital 17 mg, menthol solution in isovaleric acid menthyl ether 80 mg) oral drops of 25 ml; Validol tablets 60 mg each; Nitroglycerin, t... Type of purchase: goods Classifier and its corresponding code: DC 021:2015: 33600000-6 — Pharmaceutical products Classification according to INN: Sulfacetamide, Classification according to ATX: S01AB04, Release form: Eye drops, 10 ml, Dose of active ingredient: 300 mg/ml, Packaging type: Vial; Lugol's solution 25 g each; Classification according to ATX: N05CB02, Classification according to INN: Barbiturates in combination with other dr...

Documents

 Tender Notice